XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Business Acquisition [Line Items]  
Net income attributable to Innoviva stockholders $ (4,500)
La Jolla Pharmaceutical Company  
Business Acquisition [Line Items]  
Revenue 100,483
Net income 32,576
Net income attributable to Innoviva stockholders $ 13,555